Medical Devices Pharmaceuticals Vaccines Medical Procedures Medical Diagnostic Equipments Digital Medicine Public health policy
Medical Devices Pharmaceuticals Vaccines Medical Procedures Medical Diagnostic Equipments Digital Medicine Public health policy
Backward All research
19 September 2025

Economic Evaluation and Budget Impact of Using Pegylated-Interferon and Ribavirin for Treatment in Patients with Chronic Hepatitis C Genotype 1

research cover
View Count
38
Share this research
Share to facebook Share to linkedin Share to x Share to bluesky
Project Code 011-377-2556
Country
Thailand
Project Duration
Start : 1 June 2013
End : 1 December 2013
Research Status
Completed 100%
Complete Research Report
Quantity 2 files
Download Count
0 times
All research
19 September 2025

Economic Evaluation and Budget Impact of Using Pegylated-Interferon and Ribavirin for Treatment in Patients with Chronic Hepatitis C Genotype 1

Research Type
Others
Related Technologies
Pharmaceuticals
Funding Source
National Health Security Office (NHSO)

Research Team

Principal Researcher
Assoc. Prof. Nattiya Kapol
Assoc. Prof. Nattiya Kapol
Co-Researcher
Surasit Lochid-amnuay
Surasit Lochid-amnuay
Yot Teerawattananon, PhD.
Yot Teerawattananon, PhD.

Related Organizations/
Supporting Organizations

Organization placeholder
National Health Security Office (NHSO)

Documents & Downloads